Abstract
In Reply.— I agree with Dr. Chmelik that long-term evaluation of patients receiving aerosolized steroids is needed, but surely, potential local side effects are greatly outweighed by the known systemic toxicity produced by orally administered steroids, the only available alternative for patients with severe asthma. Aerosolized steroids, particularly beclomethasone, have now been used for more than two years, their efficacy and freedom from serious toxicity have been amply substantiated in the medical literature, and they should be made available for patients in the United States, as they are in most other parts of the world.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
